Inhibikase Therapeutics (IKT) Stock Chart & Stock Price History $1.54 +0.01 (+0.65%) Closing price 10/24/2025 04:00 PM EasternExtended Trading$1.54 0.00 (0.00%) As of 10/24/2025 04:40 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Inhibikase Therapeutics Stock Price Performance The Inhibikase Therapeutics (IKT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 36.36%, with a year-to-date return of -52.62%. In the past month, the stock has decreased 0.65%, reflecting recent market activity. As of the latest close, Inhibikase Therapeutics traded at $1.54 with a market cap of $114.76 million and volume of 75,105 shares. Receive IKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance-4.94%1 Month Performance-0.65%3 Month Performance-12.99%Year-To-Date Performance-52.62%1 Year Performance-36.36% IKT Stock Chart for Saturday, October, 25, 2025 IKT Chart by TradingView Inhibikase Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization10/24/2025$1.53$1.54+0.65%$1.56$1.4975,105 shs$114.76 million10/23/2025$1.54$1.53-0.65%$1.56$1.5020,281 shs$114.01 million10/22/2025$1.58$1.54-2.53%$1.61$1.49106,385 shs$114.76 million10/21/2025$1.62$1.58-2.47%$1.62$1.5549,876 shs$117.74 million10/20/2025$1.57$1.62+3.18%$1.65$1.5692,503 shs$120.72 million10/17/2025$1.51$1.57+3.97%$1.65$1.47217,278 shs$116.99 million10/16/2025$1.60$1.51-5.63%$1.66$1.47236,081 shs$112.52 million10/15/2025$1.62$1.60-1.23%$1.67$1.55128,862 shs$119.23 million10/14/2025$1.63$1.62-0.61%$1.63$1.5373,065 shs$120.72 million10/13/2025$1.61$1.63+1.24%$1.67$1.5861,257 shs$121.46 million Get the Latest News and Ratings for IKT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 10/10/2025$1.66$1.61-3.01%$1.68$1.5993,502 shs$119.97 million10/09/2025$1.66$1.66$1.68$1.60102,208 shs$123.70 million10/08/2025$1.62$1.66+2.47%$1.75$1.60180,887 shs$123.70 million10/07/2025$1.62$1.62$1.65$1.5751,702 shs$120.72 million10/06/2025$1.66$1.62-2.41%$1.67$1.5991,994 shs$120.72 million10/03/2025$1.64$1.66+1.22%$1.70$1.5775,316 shs$123.70 million10/02/2025$1.61$1.64+1.86%$1.67$1.5968,184 shs$122.21 million10/01/2025$1.62$1.61-0.62%$1.66$1.5741,581 shs$119.97 million09/30/2025$1.53$1.62+5.88%$1.63$1.50122,750 shs$120.72 million09/29/2025$1.55$1.53-1.29%$1.56$1.5065,193 shs$114.01 million09/26/2025$1.55$1.55$1.60$1.5088,634 shs$115.50 million09/25/2025$1.72$1.55-9.88%$1.72$1.5379,503 shs$115.50 million09/24/2025$1.62$1.72+6.17%$1.75$1.61230,668 shs$128.17 million Related Companies INBX Stock Price Chart ATXS Stock Price Chart CYRX Stock Price Chart SLDB Stock Price Chart ALMS Stock Price Chart DRUG Stock Price Chart LXEO Stock Price Chart RAPT Stock Price Chart AUTL Stock Price Chart CGEM Stock Price Chart Receive IKT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Inhibikase Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:IKT) was last updated on 10/25/2025 by MarketBeat.com Staff From Our PartnersNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredClaim Your Share of $5.39 BILLION in AI Equity ChecksThe U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredBuy UBER immediatelyBULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibikase Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Inhibikase Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IKT Stock Alerts